Paper657992
Antiplatelet agents in coronary disease: are they of prophylactic value?
Verstraete M. Drugs, 1978. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antiplatelet agents in coronary disease: are they of prophylactic value? Papers, record 657992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/657992
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Fibrinolytic Agents | Major topic |
| Angina Pectoris | |
| Aspirin | |
| Cardiopulmonary Bypass | |
| Clofibrate | |
| Dipyridamole | |
| Heart Valve Prosthesis | |
| Humans | |
| Myocardial Infarction | |
| Recurrence | |
| Sulfinpyrazone |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,340,622 | Dipyridamole in the treatment of angina pectoris. A double-blind evaluation. | JAMA | 1967 | https://conductscience.org/library/papers/5340622 | PubMed |
| 2 | 5,045,046 | Use of Persantine in preventing thromboembolism following valve replacement. | Am Surg | 1972 | https://conductscience.org/library/papers/5045046 | PubMed |
| 3 | 4,578,364 | A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress. | Bull World Health Organ | 1973 | https://conductscience.org/library/papers/4578364 | PubMed |
| 4 | 4,472,175 | Letter: Difficulties of classification and terminology of syndromes of multiple congenital anomalies. | Am J Dis Child | 1974 | https://conductscience.org/library/papers/4472175 | PubMed |
| 5 | 5,164,582 | Cerebral embolization: prospective clinical analysis of 42 cases. | Stroke | 1971 | https://conductscience.org/library/papers/5164582 | PubMed |
| 6 | 4,943,605 | Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region. | Br Med J | 1971 | https://conductscience.org/library/papers/4943605 | PubMed |
| 7 | 13,788,617 | A controlled clinical trial of 'persantin' (R A 8) in angina pectoris. | S Afr Med J | 1961 | https://conductscience.org/library/papers/13788617 | PubMed |
| 8 | 1,082,802 | Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts. | Circulation | 1976 | https://conductscience.org/library/papers/1082802 | PubMed |
| 9 | 5,667,468 | Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. | N Engl J Med | 1968 | https://conductscience.org/library/papers/5667468 | PubMed |
| 10 | 4,931,099 | Pharmacologic control of thromboembolic complications of cardiac-valve replacement. | N Engl J Med | 1971 | https://conductscience.org/library/papers/4931099 | PubMed |
| 11 | 4,943,606 | Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. | Br Med J | 1971 | https://conductscience.org/library/papers/4943606 | PubMed |
| 12 | 13,824,151 | Controlled double-blind trial of "persantin" in treatment of angina pectoris. | Br Med J | 1960 | https://conductscience.org/library/papers/13824151 | PubMed |
| 13 | 5,066,667 | Clofibrate in coronary heart disease. Effect on morbidity and mortality. | JAMA | 1972 | https://conductscience.org/library/papers/5066667 | PubMed |
| 14 | 4,828,572 | Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. | Atherosclerosis | 1974 | https://conductscience.org/library/papers/4828572 | PubMed |
| 15 | 4,816,857 | Regular aspirin intake and acute myocardial infarction. | Br Med J | 1974 | https://conductscience.org/library/papers/4816857 | PubMed |
| 16 | 340,942 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. | N Engl J Med | 1978 | https://conductscience.org/library/papers/340942 | PubMed |
| 17 | 5,044,479 | Platelet survival in patients with a Beall valve. Relation to low incidence of thromboembolism. | Am J Cardiol | 1972 | https://conductscience.org/library/papers/5044479 | PubMed |
| 18 | 15,215,986 | AORTOCORONARY BYPASS SURGERY, 1969-1973: REVIEW OF 2566 PATIENTS. | Cardiovasc Dis | 1974 | https://conductscience.org/library/papers/15215986 | PubMed |
| 19 | 4,879,059 | Dipyridamole: a controlled trial of its effect in acute myocardial infarction. | Br Med J | 1968 | https://conductscience.org/library/papers/4879059 | PubMed |
| 20 | 14,100,905 | SOME EFFECTS OF ATROMID ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN. | J Atheroscler Res | 1963 | https://conductscience.org/library/papers/14100905 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,894,509 | The effect of antiaggregating drugs on the patency of grafts in the arterial system. | World J Surg | 1980 | https://conductscience.org/library/papers/6894509 | PubMed |
| 6,113,147 | Induction of drug metabolizing enzymes by sulfinpyrazone. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6113147 | PubMed |
| 391,530 | Antiplatelet drugs: clinical pharmacology and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/391530 | PubMed |
| 350,557 | Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. | Drugs | 1978 | https://conductscience.org/library/papers/350557 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/657992
GET https://conductscience.org/api/papers/v1/657992/references?page=2